mTOR Inhibitor-1>98.0%(HPLC)5mg

4-Bromotetrafluoroaniline, 97.0%, 1g

4-methyl-6-piperazin-1-ylpyrimidine, 95.0%, 1g

1-Oxa-6-azaspiro[2,5]octane-6-carboxylic acid tert-butyl ester, 95.0%, 1g

5-(Tert-butyl)-2-hydroxy-3-methylbenzaldehyde, 98%, 2.5g

4-Acetylphenylacetylene, 95.0%, 10g

Phosphocholine Chloride Sodium Salt [for Cholinesterase Substrate]>98.0%(N)5g

6-Bromo-2-methyl-quinoline-4-carboxylic acid, 95.0%, 500mg

2-Methylimidazole, 98.0%, 500g

2-methyl-1,3-thiazole-4-carboxylic acid - carbonic acid (1:1), 95.0%, 1g

5-Methylindole>99.0%(GC)1g

4-Bromobenzene-1,3-diol, 95.0%, 1g

1,1'-Oxybis(propan-2-ol) (mixture of isomers), 97.0%, 100g